← Back to all trials
Enrolling By Invitation
NCT07634133
The Impact of Omega-3 Fatty Acid Supplementation on the Composition of Erythrocyte Membranes
Conditions: Healthy Volunteers
Sex: Male
Ages: 18 Years – 60 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 200
Sponsor: The Jerzy Kukuczka Academy of Physical Education in Katowice
Location: Academy of Physical Education in Katowice Katowice
Summary
Therefore, the aim of our project will be to assess the impact of omega-3 fatty acid on the neuromuscular system (muscle tensomyography- TMG), the composition and fluidity of erythrocyte cell membranes, the lipid profile and the antioxidant status of the blood.
Eligibility Criteria
\*\*Inclusion Criteria:\*\*
* Male participants aged 20-40 years.
* Apparently healthy individuals, as determined by medical history and self-reported health status.
* Physically active, engaging in regular physical activity at least 3 times per week for the previous 6 months.
* Following a mixed diet.
* Willingness to maintain habitual dietary and physical activity patterns throughout the study.
* Willingness to refrain from consuming dietary supplements other than those provided as part of the study.
\*\*Exclusion Criteria:\*\*
* Current use of dietary supplements within 4 weeks prior to enrollment.
* Following a low-carbohydrate, ketogenic, high-carbohydrate, vegetarian, or vegan diet.
* Presence of gastrointestinal disorders affecting nutrient absorption, including irritable bowel syndrome, inflammatory bowel disease, celiac disease, or other clinically significant gastrointestinal conditions.
* History of cardiovascular, metabolic, endocrine, hepatic, renal, neurological, or autoimmune diseases.
* Current use of medications known to affect lipid metabolism, inflammation, antioxidant status, or cognitive function.
* Known allergy or intolerance to study supplements or their ingredients.
* Participation in another clinical trial within the previous 3 months.
Source: ClinicalTrials.gov (NCT07634133). StuddyBuddy aggregates publicly available trial information.